Boston Scientific Corporation logo

Boston Scientific Corporation (BSX)

Market Closed
16 Oct, 08:00 PM
NYSE NYSE
$
44. 39
+0.25
+0.5664%
After Hours
$
44. 50
+0.11 +0.2478%
62.49B Market Cap
74.55 P/E Ratio
- Div Yield
12.41M Volume
2.01 Eps
$ 44.14
Previous Close
Add Transaction
Day Range
43.89 44.83
Year Range
41.39 105.65
Want to track BSX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Boston Scientific (BSX) Surges 6.8%: Is This an Indication of Further Gains?

Boston Scientific (BSX) Surges 6.8%: Is This an Indication of Further Gains?

Boston Scientific (BSX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

Zacks | 1 year ago
Here's Why Boston Scientific (BSX) is a Strong Growth Stock

Here's Why Boston Scientific (BSX) is a Strong Growth Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks | 1 year ago
3 Stocks to Buy for "Liberation" From Trump Tariffs & Recession Woes

3 Stocks to Buy for "Liberation" From Trump Tariffs & Recession Woes

In 2025, companies like MASI, BSX and HIMS are expected to overcome challenges and sustain strong growth and market leadership.

Zacks | 1 year ago
Boston Scientific (BSX) Exceeds Market Returns: Some Facts to Consider

Boston Scientific (BSX) Exceeds Market Returns: Some Facts to Consider

Boston Scientific (BSX) reachead $100.88 at the closing of the latest trading day, reflecting a +1.53% change compared to its last close.

Zacks | 1 year ago
International Expansion, Product Launches Support BSX Stock

International Expansion, Product Launches Support BSX Stock

Boston Scientific continues to successfully expand its operations across various geographies outside the United States.

Zacks | 1 year ago
Medical Products Leader Tops These Early-Bird Buy Points

Medical Products Leader Tops These Early-Bird Buy Points

Boston Scientific has the highest Composite Rating of 126 companies in the medical products industry. The post Medical Products Leader Tops These Early-Bird Buy Points appeared first on Investor's Business Daily.

Investors | 1 year ago
Boston Scientific (BSX) Exceeds Market Returns: Some Facts to Consider

Boston Scientific (BSX) Exceeds Market Returns: Some Facts to Consider

In the closing of the recent trading day, Boston Scientific (BSX) stood at $102.67, denoting a +1.97% change from the preceding trading day.

Zacks | 1 year ago
Fed's Stagflation Fears Weigh, Yet Growth Factors Make BSX Stock a Buy

Fed's Stagflation Fears Weigh, Yet Growth Factors Make BSX Stock a Buy

Boston Scientific, with substantial operations in China and Europe, faces significant risks due to escalating global trade tensions in 2025.

Zacks | 1 year ago
Is Boston Scientific Stock a Smart Pick for Your Portfolio Right Now?

Is Boston Scientific Stock a Smart Pick for Your Portfolio Right Now?

Investors continue to be optimistic about BSX, courtesy of its international expansion efforts and WATCHMAN's performance.

Zacks | 1 year ago
Boston Scientific Gains 42.2% in a Year: What's Driving the Stock?

Boston Scientific Gains 42.2% in a Year: What's Driving the Stock?

BSX's shares rise on the back of its innovative product portfolio and impressive value-added acquisition. However, the unfavorable macroeconomic scenario is concerning.

Zacks | 1 year ago
Is Trending Stock Boston Scientific Corporation (BSX) a Buy Now?

Is Trending Stock Boston Scientific Corporation (BSX) a Buy Now?

Boston Scientific (BSX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Zacks | 1 year ago
Is It Worth Investing in Boston Scientific (BSX) Based on Wall Street's Bullish Views?

Is It Worth Investing in Boston Scientific (BSX) Based on Wall Street's Bullish Views?

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?

Zacks | 1 year ago
Loading...
Load More